TWO SIGMA INVESTMENTS, LP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2022$23,000
-84.8%
41,091
-69.6%
0.00%
Q1 2022$151,000
-80.0%
135,101
-73.9%
0.00%
-100.0%
Q4 2021$756,000
-4.7%
517,808
+96.0%
0.00%0.0%
Q3 2021$793,000
+6.6%
264,216
+64.9%
0.00%0.0%
Q2 2021$744,000
+2.3%
160,273
+32.2%
0.00%0.0%
Q1 2021$727,000
+634.3%
121,239
+960.2%
0.00%
Q2 2020$99,000
-60.6%
11,436
-67.1%
0.00%
-100.0%
Q4 2019$251,00034,7660.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders